The new company combines Tahoe’s AI-powered target discovery engine with Alloy’s industry-leading ADC development ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

Leonard Jacoby, half of the duo behind the firm that pushed new forms of advertising and revolutionized the legal industry, ...

While LaValle’s main target is the failing US health system, his sprawling and slightly in-need-of-pruning novel takes in ...

Yulin Kuang, Amos Vernon and Nunzio Randazzo talk about capturing the “spirit” of the author’s bestseller, the intimidation ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5M seed funding round. The Company ...

Svetlana Satchkova’s English-language debut explores an uncomfortable reality in which opportunities for rebellion are slim ...

The US president vowed to ‘end childhood cancer’. But his administration is dismantling the search for a cure and sending families scrambling for treatment ...

The explosive popularity of the gay hockey TV drama reveals women’s desire for sex and romance without violence or hierarchy ...

A Cambridge-based firm which applies AI predictive genomics to drug target discovery has completed a £2.5m seed funding round and signed a new partnership.

Batman's live-action suits can be silly and clunky or gothic and visually arresting, just like the Dark Knight himself.

This year is stacked with sequels and yet another superhero movie because in Hollywood new ideas are expensive.